home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Stryker Corp (NY:SYK)

326.10 -1.34 (-0.41%)

Official Closing Price Updated: 7:00 PM EDT, Mar 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stryker declares a $0.75 per share quarterly dividend

February 09, 2023

From Stryker Corporation

Via GlobeNewswire

General Motors, Bank of America And 2 Other Stocks Insiders Are Selling ↗

February 07, 2023

The Nasdaq dropped by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Price Reversals From Recent Highs In Stocks ↗

February 06, 2023

Stryker Corp is in a bullish phase on both the daily and weekly charts. Since Friday, the stock had a brick pattern confirmed by Monday’s action.

Via Talk Markets

Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday ↗

February 01, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Stryker Expects Good Momentum In 2023 Despite Some Volatility ↗

February 01, 2023

Via Benzinga

Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today ↗

January 31, 2023

Via Benzinga

Stryker's Earnings: A Preview ↗

January 30, 2023

Via Benzinga

Texas Rep. Michael C. Burgess Sold Up to $500K Worth of Stryker Stock ↗

January 26, 2023

Via Benzinga

Stryker reports 2022 operating results and 2023 outlook

January 31, 2023

From Stryker Corporation

Via GlobeNewswire

Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades' ↗

January 31, 2023

On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth,

Via Benzinga

Earnings Scheduled For January 31, 2023 ↗

January 31, 2023

Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter.

Via Benzinga

Stryker's Debt Overview ↗

January 25, 2023

Shares of Stryker Inc. (NYSE:SYK) increased by 10.06% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023 ↗

January 25, 2023

Via Benzinga

8 Analysts Have This to Say About Stryker ↗

January 25, 2023

Via Benzinga

Analyst Boosts Stryker Price On Easing Staffing, Macro Pressures ↗

January 09, 2023

Via Benzinga

Expert Ratings for Stryker ↗

January 09, 2023

Via Benzinga

Golden Cross Appears Before Stryker Investors ↗

December 21, 2022

Via Benzinga

9 Analysts Have This to Say About Stryker ↗

December 20, 2022

Via Benzinga

Is This Dividend Growth Stock a Buy? ↗

December 07, 2022

The medical devices giant has outperformed the S&P 500 index so far in 2022.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023 ↗

January 09, 2023

Via Benzinga

Adobe To Rally 25%? Here Are 10 Other Analyst Forecasts For Monday ↗

January 09, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 29, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Stryker to host conference call on January 31, 2023

December 28, 2022

From Stryker Corporation

Via GlobeNewswire

Rivian Automotive, Stryker, Ardagh Metal Packaging And This Tech Stock Are CNBC's 'Final Trades' ↗

December 22, 2022

On CNBC’s "Halftime Report Final Trades," Joseph Terranova of Virtus Investment Partners named VeriSign, Inc. (NASDAQ: VRSN), which is higher month-to-date and also gai

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

December 14, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

We Are the Champions: 3 Dividend Growers Wall Street Loves

December 14, 2022

A way to gain exposure to dividend growers is to invest in a handful of companies across sectors. These are a few of the names research firms like the most.

Via MarketBeat

Topics ETFs

Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process

December 13, 2022

From Stryker

Via Business Wire

Stryker, Freeport-McMoRan, Southwest Gas And This Health Care Major Feature On CNBC's 'Final Trades' ↗

December 09, 2022

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors chose Stryker Corporation (NYSE: SYK), saying all medical procedures that

Via Benzinga

Stryker declares a $0.75 per share quarterly dividend

December 07, 2022

From Stryker Corporation

Via GlobeNewswire

2 Top Healthcare Stocks to Buy Right Now ↗

December 02, 2022

A growing and aging global population serves as a major tailwind for the healthcare sector.

Via The Motley Fool

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com